期刊文献+

直肠癌手术加术中放疗和单纯手术的疗效比较 被引量:3

Surgery combined with intraoperative radiotherapy compared with surgery alone for rectal carcinoma
暂未订购
导出
摘要 目的 :探讨手术合并术中放疗对直肠癌的疗效。方法 :97例直肠癌患者在手术切除病灶后 ,用 9~16MeV电子线照射瘤床及周围淋巴引流区 ,照射剂量在 10~ 3 0Gy之间。并与单纯手术组 12 2例进行同期对照。结果 :DukesA期直肠癌手术加术中放疗对五年局部复发率和生存率无影响 ,DukesB期较单纯手术组三年、五年局部复发率分别下降 19%、2 0 .2 % ,三年、五年生存率分别提高 19.9%、2 7.2 % (P <0 .0 1) ;DukesC期较单纯手术组三年、五年局部复发率分别下降 2 8.8%、2 6.7% ,三年、五年生存率则分别提高 2 2 .2 %、3 2 .9% (P <0 .0 5) ;DukesD期患者较单纯手术组五年局部复发率虽下降 2 6.0 % ,但无统计学意义 ,五年生存率未见提高。术中放疗有可能增加粘连性肠梗阻的发生 ,无其他严重并发症。结论 :手术结合术中放疗能提高DukesB期、C期直肠癌的三年。 Purpose:To assess the effect of surgery combined with intraoperative radiotherapy (IORT) in the treatment of rectal carcinoma.Methods:97 patients with rectal carcinoma underwent IORT with 10~30Gy by 9~16MeV elect ro n beam to the tumor bed and local lymphatic regions. Another 122 patients treate d by surgery alone served as control.Results:Surgery combined w ith IORT did not improve the 5-year survival rate and local recurrence rate in the stage Dukes A patients. IORT have increased the 3-year and the 5-year surv ival rates in the stage Dukes B patients to 19.9%?27.2%, decreased their local recurrence rates to 19%?20.2%(P<0.01), increased the 3-year and the 5-yea r survival rates in the stage Dukes C patients to 22.2%?32.9%, decreased their local recurrence rates to 28.8%?26.7% (P<0.05);in the stage Dukes D patien ts, 5-year local recurrence rate decreased 26.0%, but there was no statistical difference, its 5-year survival rate did not increase. No serious complication s except adhesive intestinal obstruction were observed in IORT group.Conclusions:surgery combined with IORT can improve the 3-year ?the 5-year survival and reduce the local recurrence in the stage Dukes B and C patients.
出处 《中国癌症杂志》 CAS CSCD 2004年第1期61-64,共4页 China Oncology
关键词 直肠癌 术中放疗 手术治疗 综合治疗 rectal carcinoma intraoperative radiotherapy surgery therapy combined treatment
  • 相关文献

参考文献4

二级参考文献18

  • 1[1]Wong CS,Cummings,et al. Treatment of locally recurrent rectal carcinomar-result and pronostic factors. Int J Radiation oncol Biol Phys,1998,40:427-435.
  • 2[2]QUASAR Collaborative Group. Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer:a randomised trial. Lancet, 2000:1588-1596.
  • 3[3]Shibata M, Nezu T, et al. Immunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer. Cancer Invest,2002, 20:166-173.
  • 4[4]Cheeseman SL, Joel SP, et al. A modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. Br J Cancer, 2002 ,87:393-399
  • 5[5]Grem JL, Quinn M, et al Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion. Cancer Chemother Pharmacol, 2001,47:117-125.
  • 6[6]Kern W, Beckert B, et al. Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol ,2001, 5:599-603.
  • 7[7]Brian W Loggie,Ronald a fleming. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin, The American Surgeon,2000,66: 561-568.
  • 8[8]Minsky BD. Sphincter preservation in rectal cancer. Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis. Semin-Radiat-Oncol, 1998,8:30-35.
  • 9[9]Fisher B, Wolmark N, Rockette H,et al. Postoperative adjuvant chemothorapy or radiation therapy for rectal cancer: results from NSABP proto Cal R-01.J Natl Cancer Inst, 1998,80:21.
  • 10[10]Brad E Waddell,R Jeffrey Lee,Miguel A, et al. Absorbable mesh sling prevents radiation-induced bowel injury during "sandwich" chemoradiation for rectal cancer. Archives of Surgery,2000,135:1212.

共引文献8

同被引文献13

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部